Ghia, P., Owen, C., Allan, J. N., Barrientos, J. C., Barr, P. M., Shi, C., . . . Burger, J. A. (2024). First‐line ibrutinib treatment in patients with chronic lymphocytic leukemia is associated with overall survival rates similar to those of an age‐matched general population: A pooled post hoc analysis. Wiley. https://doi.org/10.1002/hem3.74
Style de citation Chicago (17e éd.)Ghia, Paolo, et al. First‐line Ibrutinib Treatment in Patients with Chronic Lymphocytic Leukemia Is Associated with Overall Survival Rates Similar to Those of an Age‐matched General Population: A Pooled Post Hoc Analysis. Wiley, 2024. https://doi.org/10.1002/hem3.74.
Style de citation MLA (9e éd.)Ghia, Paolo, et al. First‐line Ibrutinib Treatment in Patients with Chronic Lymphocytic Leukemia Is Associated with Overall Survival Rates Similar to Those of an Age‐matched General Population: A Pooled Post Hoc Analysis. Wiley, 2024. https://doi.org/10.1002/hem3.74.